decisionhealth Newsletters, Coder Pink Sheets - 2002 Issue 8 (August)
Drug-eluting stents
Subscribe or sign in to view the full article.
Article Overview
This premium article covers coding and reimbursement guidance for drug-eluting stents in the context of early investigational use and clinical trials. It is aimed at physicians, facility billers, and coding professionals who need to understand the applicable CPT and APC reporting framework, related documentation elements, and the distinction between professional and facility payment handling. The article also references the organizations and claim fields involved in reporting these services.
Why This Topic Matters
Drug-eluting stents created billing and reimbursement uncertainty because they were treated differently depending on setting and trial participation. Understanding the article helps coders and billers identify the relevant reporting framework and avoid claim submission errors.
Article Sections
-
Coding and reimbursement overview
Introduces the topic and explains the general billing context for drug-eluting stents in physician and facility settings.
-
Clinical trial and investigational status
Discusses the investigational context, trial participation, and federal oversight referenced in the article.
-
Reporting and claim documentation
Covers the claim reporting elements and administrative fields mentioned for related stent services and facility billing.
What You Will Learn
- How the article frames coding for drug-eluting stents in a reimbursement context
- Which general billing settings are discussed
- What documentation and claim-reporting topics are referenced
- Which organizations and code sets are involved in the discussion
Who Should Read This
- Physician office billers
- Facility coders
- Medical coding professionals
- Reimbursement staff
- Cardiology practices
Codes Discussed
Code Ranges Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com